Also transcription factors of the nuclear factor kappa B (NFκB) pathway were differentially expressed in C9-ALS and non-C9-ALS patients compared to healthy subjects (Ismail et al., 2013), but it is unclear in which cells these alterations occur. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.